B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review

B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro BNP) are cardiac biomarkers that are released in response to increased ventricular and atrial wall stress. Aortic stenosis (AS) leads to hemodynamic changes and left ventricular hypertrophy and may be associated with natriuretic peptide levels. Several studies have shown that increased natriuretic peptide levels are correlated with AS severity and can predict the need for intervention. It can be useful in risk stratification, monitoring follow-up, and predicting cardiovascular outcomes of patients with severe AS. This paper aims to summarize the evidence of the role of BNP and NT-pro BNP in AS, before and after intervention.

[1]  Luciano de Moura Santos,et al.  Multimodality imaging methods and systemic biomarkers in classical low-flow low-gradient aortic stenosis: Key findings for risk stratification , 2023, Frontiers in Cardiovascular Medicine.

[2]  Helen Huang,et al.  Early surgery vs conservative management among asymptomatic aortic stenosis: A systematic review and meta-analysis , 2022, International journal of cardiology. Heart & vasculature.

[3]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). , 2022, Revista espanola de cardiologia.

[4]  Sunao Nakamura,et al.  Prognostic relevance of B‐type natriuretic peptide in patients with moderate mixed aortic valve disease , 2022, ESC heart failure.

[5]  Rizwan Kalani,et al.  Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association , 2022, Circulation.

[6]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.

[7]  T. Nishikimi,et al.  Potential pitfalls when interpreting plasma BNP levels in heart failure practice. , 2021, Journal of cardiology.

[8]  K. Koskinas,et al.  Biomarkers Associated with Mortality in Aortic Stenosis: A Systematic Review and Meta-Analysis , 2021, Medical sciences.

[9]  H. Baumgartner,et al.  Usefulness of the B-Type Natriuretic Peptides in Low Ejection Fraction, Low-Flow, Low-Gradient Aortic Stenosis Results from the TOPAS Multicenter Prospective Cohort Study , 2021 .

[10]  M. Mack,et al.  2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.

[11]  I. Monte,et al.  Severe Aortic Valve Stenosis: Symptoms, Biochemical Markers, and Global Longitudinal Strain , 2020, Journal of cardiovascular echography.

[12]  M. Niemelä,et al.  B-type natriuretic peptide ability to predict mortality after transcatheter aortic valve replacement , 2020, Journal of cardiovascular medicine.

[13]  M. Volpe,et al.  BNP level and post-transcatheter aortic valve replacement outcome: an intriguing J-shaped relationship. , 2020, European heart journal.

[14]  T. Nazif,et al.  Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry. , 2019, European heart journal.

[15]  B. Prendergast,et al.  Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. , 2019, European heart journal.

[16]  P. Pibarot,et al.  Impact of left ventricular remodelling patterns on outcomes in patients with aortic stenosis , 2017, European heart journal cardiovascular Imaging.

[17]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[18]  P. Pibarot,et al.  B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis: A Substudy of the TOPAS Study. , 2017, JACC. Cardiovascular imaging.

[19]  K. Takagi,et al.  Elevation of B‐Type Natriuretic Peptide at Discharge is Associated With 2‐Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN‐TAVI (Optimized Transcatheter Valvular Intervention–Transcatheter Aortic Valve , 2017, Journal of the American Heart Association.

[20]  D. Burkhoff,et al.  Biomarkers in Aortic Stenosis: A Systematic Review , 2017 .

[21]  M. Desai,et al.  Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Strain in Patients With Significant Aortic Stenosis , 2016, Journal of the American Heart Association.

[22]  R. Makkar,et al.  Impact of Preprocedural B-Type Natriuretic Peptide Levels on the Outcomes After Transcatheter Aortic Valve Implantation. , 2015, The American journal of cardiology.

[23]  M. Enriquez-Sarano,et al.  Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. , 2014, Journal of the American College of Cardiology.

[24]  P. Pibarot,et al.  Prognostic value of plasma B-type natriuretic peptide levels after exercise in patients with severe asymptomatic aortic stenosis , 2014, Heart.

[25]  A. Jaffe,et al.  B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. , 2014, Journal of the American College of Cardiology.

[26]  P. Pibarot,et al.  Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation. , 2014, The American journal of cardiology.

[27]  F. Gudé,et al.  Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation. , 2013, International journal of cardiology.

[28]  R. Lopes,et al.  Natriuretic peptides and long-term mortality in patients with severe aortic stenosis. , 2012, The Journal of heart valve disease.

[29]  E. Donal,et al.  Clinical outcome in asymptomatic severe aortic stenosis: insights from the new proposed aortic stenosis grading classification. , 2012, Journal of the American College of Cardiology.

[30]  S. Nakatani,et al.  Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[31]  J. Clarke,et al.  What is a systematic review? , 2011, Evidence Based Nursing.

[32]  L. Tarantini,et al.  Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis , 2010, Heart.

[33]  G. Feuchtner,et al.  Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg). , 2008, The American journal of cardiology.

[34]  A. Auricchio,et al.  Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. , 2008, The American journal of cardiology.

[35]  B. Popescu,et al.  Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement. , 2008, International journal of cardiology.

[36]  J. Nielsen-Kudsk,et al.  Recovery of left ventricular systolic longitudinal strain after valve replacement in aortic stenosis and relation to natriuretic peptides. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[37]  G. Feuchtner,et al.  Aortic valve calcification as quantified with multislice computed tomography predicts short-term clinical outcome in patients with asymptomatic aortic stenosis. , 2006, The Journal of heart valve disease.

[38]  J. Garot,et al.  Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function : role of B-type natriuretic peptide ded from , 2004 .

[39]  C. Hamm,et al.  Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. , 2004, The American journal of cardiology.

[40]  H. Baumgartner,et al.  Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis , 2004, Circulation.

[41]  H. White,et al.  Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis , 2003, Circulation.

[42]  J. Schaper,et al.  Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart: Structural Deterioration and Compensatory Mechanisms , 2003, Circulation.

[43]  Alan S Maisel,et al.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[44]  R. Berger,et al.  B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002, Circulation.

[45]  P. Mathisen,et al.  Natriuretic peptides in patients with aortic stenosis. , 2001, American heart journal.

[46]  D. Fukai,et al.  Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. , 1997, Circulation.

[47]  H. Itoh,et al.  Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. , 1997, American heart journal.

[48]  K. Bailey,et al.  Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. , 1996, Hypertension.

[49]  M. Mendes,et al.  Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation. , 2018, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[50]  M. Biddle,et al.  A report from the American Heart Association Council on Cardiovascular and Stroke Nursing. , 2015, The Journal of cardiovascular nursing.

[51]  E. Donal,et al.  194 Clinical outcome in asymptomatic severe aortic stenosis. Insights from the new proposed aortic stenosis grading classification , 2012 .

[52]  김태선,et al.  Role of B-type natriuretic peptide in the recurrence of atrial fibrillation after electrical cardioversion , 2009 .